Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
4
×
eli lilly
4
×
fda
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
abbvie
allergan
astrazeneca
avexis
bristol-myers squibb
calcitonin gene-related peptide
celgene
drugs
eptinezumab
What
fda
4
×
drug
won
approval
bio
class
companies
drugs
migraine
new
news
roundup
amgen
approved
arguments
august
big
biotech
busy
candidates
commercialized
competitors
days
decades
decisions
developed
devices
digital
disease
epidemic
fatty
frenzied
gets
growing
head
known
led
legacy
liver
make
Language
unset
Current search:
fda
×
biotech
×
" detroit top stories "
×
" eli lilly "
×
photo
×
fda
×
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines